In a spinal cord injury and cognitive impairment-based study in rats, ginsenoside Rb1 improves injury and cognitive impairment via NRF2 and PI3K/AKT inflammatory signaling pathways [227, 228]. The gene discussed is AKT1; the disease is Cognitive impairment.